Neovacs
Biotech development company
Neovacs has raised €8.0M across 2 funding rounds from 1 investor, most recently a round in Aug 2021. Based in France; active in Healthtech. Data as of Nov 2026.
Total raised
€8.0M
€8,000,000
Funding rounds
2
Investors
1
distinct backers
Active since
2017-07
latest 2021-08
Funding by year
EUR raised per yearNeovacs — funding by year — interactive chart.
Data table
| Neovacs — funding by year | |
|---|---|
| 2017 | €6.0M |
| 2021 | €2.0M |
Signals
High confidenceRaise-next likelihood5
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
- ▲ 9y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-08-19 | Other | €2.0M | European High Growth Opportunities Securitization Fund | View deal → |
| 2017-07-07 | Other | €6.0M | — | View deal → |
Related news
Similar companies
same sector, similar size- Kazidomi€7.5MFrance · Healthtech
- Advanced BioDesign€9.0MFrance · Healthtech
- Vect-Hours€6.7MFrance · Healthtech
- AcuSurgical€5.8MFrance · Healthtech
- Allisone€10MFrance · Healthtech
- wefight€12MFrance · Healthtech
Global coverage: FundingData